Inmune Bio (INMB) Change in Cash (2018 - 2026)

Inmune Bio has reported Change in Cash for 9 years, with the latest figure at -$3.4 million in Q1 2026.

• Quarterly Change in Cash fell 114.07% year-over-year to -$3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 130.32% YoY) and the FY2025 annual result came in at $3.8 million, up 125.65% from the prior year.
• Change in Cash retreated to -$3.4 million in Q1 2026 per INMB's latest filing, from -$3.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $14.0 million in Q2 2025 and troughed at -$12.6 million in Q4 2024.
• A 5-year average of -$3.1 million and a median of -$3.8 million in 2022 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 259.44% in 2024, down 756.17% in 2024.
• Over 5 years, Change in Cash stood at -$5.3 million in 2022, then decreased by 13.58% to -$6.0 million in 2023, then sank by 111.74% to -$12.6 million in 2024, then jumped by 76.38% to -$3.0 million in 2025, then dropped by 13.74% to -$3.4 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$3.4 million, -$3.0 million, and -$5.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.